Interleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 413 (15-16), 1163-1170
- https://doi.org/10.1016/j.cca.2012.03.021
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
This publication has 137 references indexed in Scilit:
- A clinical perspective of IL‐1β as the gatekeeper of inflammationEuropean Journal of Immunology, 2011
- The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitusNature Clinical Practice Endocrinology & Metabolism, 2008
- The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart StudyExperimental and Molecular Pathology, 2007
- Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory CytokinesExperimental and Clinical Endocrinology & Diabetes, 2007
- IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?FEBS Letters, 2006
- Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene ExpressionJournal of Biological Chemistry, 2002
- Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cellsFEBS Letters, 1994
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Cyclic AMP and interleukin 1 signal transductionImmunology Today, 1990
- Interleukin-1 receptor antagonist: Discovery, structure and propertiesProgress in Growth Factor Research, 1990